Ruediger Spitz
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
- Neurofibromatosis and Schwannoma Cases
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 11
- Neuroblastoma Research and Treatments 11
- Neurofibromatosis and Schwannoma Cases 1
-
- Cancer therapeutics and mechanisms 2
- Ion channel regulation and function 1
- RNA modifications and cancer 1
- Co-authors
- Frank Berthold (12 shared papers)Barbara Hero (11 shared papers)Karen Ernestus (8 shared papers)Thorsten Simon (6 shared papers)Freimut H. Schilling (2 shared papers)Astrid Gnekow (1 shared paper)Dirk Schwabe (1 shared paper)G. Benz-Bohm (1 shared paper)
- Journals
- Genes Chromosomes and Cancer (3 papers)Clinical Cancer Research (2 papers)Journal of Clinical Oncology (1 paper)Diagnostic Molecular Pathology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Ruediger Spitz
12 papers receiving 664 citations
Peers
Comparison fields: 5 of 38
- Neurology 611
- Cancer Research 195
- Oncology 118
- Genetics 44
- Molecular Biology 254
Countries citing papers authored by Ruediger Spitz
This map shows the geographic impact of Ruediger Spitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Spitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Spitz more than expected).
Fields of papers citing papers by Ruediger Spitz
This network shows the impact of papers produced by Ruediger Spitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Spitz. The network helps show where Ruediger Spitz may publish in the future.
Co-authors
The 23 scholars most cited alongside Ruediger Spitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 212 | |
| 2 | Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. | 2003 | 97 |
| 3 | 2006 | 71 | |
| 4 | 2006 | 64 | |
| 5 | 2004 | 47 | |
| 6 | 2009 | 38 | |
| 7 | 2003 | 37 | |
| 8 | 2002 | 34 | |
| 9 | 2006 | 29 | |
| 10 | 2014 | 28 | |
| 11 | Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. | 2003 | 26 |
| 12 | 2005 | 6 |
About Ruediger Spitz
Ruediger Spitz is a scholar working on Neurology, Molecular Biology, Oncology, Epidemiology and Cancer Research, having authored 12 papers that have together received 689 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (11 papers), Lung Cancer Research Studies (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer therapeutics and mechanisms (2 papers), Ion channel regulation and function (1 paper), Neurofibromatosis and Schwannoma Cases (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Neurology (611 citations), Cancer Research (195 citations), Oncology (118 citations), Genetics (44 citations) and Molecular Biology (254 citations). Ruediger Spitz has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Frank Berthold, Barbara Hero, Karen Ernestus, Thorsten Simon, Freimut H. Schilling, Astrid Gnekow, Dirk Schwabe, G. Benz-Bohm, Manfred Schwab and André Oberthuer. Their work appears in journals such as Genes Chromosomes and Cancer, Clinical Cancer Research, Journal of Clinical Oncology, Diagnostic Molecular Pathology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.